⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for suramin

Every month we try and update this database with for suramin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Suramin in Treating Patients With Recurrent Primary Brain TumorsNCT00002639
Brain and Centr...
chemotherapy
suramin
15 Years - National Cancer Institute (NCI)
Suramin in Treating Patients With Recurrent Bladder CancerNCT00006476
Bladder Cancer
suramin
conventional su...
18 Years - National Cancer Institute (NCI)
Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung CancerNCT01671332
Carcinoma, Non ...
Docetaxel
Suramin
Docetaxel
18 Years - University of Wisconsin, Madison
A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate CarcinomaNCT00001266
Prostatic Neopl...
Suramin
- National Institutes of Health Clinical Center (CC)
Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung CancerNCT00066768
Recurrent Non-s...
Stage IIIB Non-...
Stage IV Non-sm...
suramin
docetaxel
gemcitabine hyd...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
Suramin in Treating Patients With Recurrent Primary Brain TumorsNCT00002639
Brain and Centr...
chemotherapy
suramin
15 Years - National Cancer Institute (NCI)
Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeNCT00004073
Brain and Centr...
suramin
radiation thera...
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by SurgeryNCT00002921
Adrenocortical ...
suramin
therapeutic hyd...
18 Years - SWOG Cancer Research Network
Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung CancerNCT01038752
Non-small Cell ...
Suramin Drug:Do...
Placebo Drug: D...
18 Years - Optimum Therapeutics, LLC
Suramin in Treating Patients With Recurrent Primary Brain TumorsNCT00002639
Brain and Centr...
chemotherapy
suramin
15 Years - National Cancer Institute (NCI)
Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's DiseaseNCT00002652
Multiple Myelom...
suramin
18 Years - National Cancer Institute (NCI)
Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerNCT00006929
Recurrent Non-s...
Stage IIIB Non-...
Stage IV Non-sm...
suramin
carboplatin
paclitaxel
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate CancerNCT00002881
Prostate Cancer
flutamide
goserelin aceta...
leuprolide acet...
suramin
therapeutic hyd...
orchiectomy
18 Years - National Cancer Institute (NCI)
Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate CancerNCT00002723
Prostate Cancer
suramin
suramin
Suramin
18 Years - National Cancer Institute (NCI)
Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast CancerNCT00054028
Recurrent Breas...
Stage IIIB Brea...
Stage IV Breast...
suramin
paclitaxel
pharmacological...
18 Years - National Cancer Institute (NCI)
Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerNCT00006929
Recurrent Non-s...
Stage IIIB Non-...
Stage IV Non-sm...
suramin
carboplatin
paclitaxel
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate CancerNCT00002881
Prostate Cancer
flutamide
goserelin aceta...
leuprolide acet...
suramin
therapeutic hyd...
orchiectomy
18 Years - National Cancer Institute (NCI)
Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) CancerNCT00083109
Recurrent Renal...
Stage IV Renal ...
Fluorouracil
Pharmacological...
Suramin
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: